Naysha Becerra-Chauca

Naysha Becerra-Chauca

Auto-generated profile, based on publicly available information

Naysha Becerra-Chauca

Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Peru

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2020 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
YHYamilée Hurtado-Roca
Yamilée Hurtado-Roca
NBNaysha Becerra-Chauca
Naysha Becerra-Chauca
MMMagaly Malca
Magaly Malca
OBJECTIVES: To determine the efficacy and safety of the use of cryotherapy, cold knife or thermocoagulation compared to Loop Electrosurgical Excision Procedure (LEEP) for the treatment of cervical intraepithelial neoplasia. METHODS: Systematic review with meta-analysis of randomized controlled trials in women with cervical intraepithelial neoplasia undergoing treatment with cryotherapy, cold knife, or thermo-coagulation compared with LEEP, to estimate its efficacy and safety. The search was conducted on MEDLINE/PUBMED, Cochrane Central Register of Controlled Trials (CENTRAL) and Scopus, until September 2018. RESULTS: The total of 72 studies were identified, of which only 8 studies met the inclusion criteria. The treatment of CIN with cold knife decreases the risk of residual disease compared with LEEP (RR, 0.54, 95%CI, 0.30–0.96, p = 0.04). The management of premalignant lesions with cryotherapy, compared with LEEP, increases the risk of disease recurrence by 86% (RR, 1.86, 95%CI, 1.16–2.97, p = 0.01), increases the risk of infections (RR, 1.17, 95%CI, 1.08–1.28, p < 0.001) and reduces the risk of minor bleeding by 51% (RR, 0.49, 95%CI) %, 0.40–0.59, p ≤ 0.001). CONCLUSIONS: The treatment of premalignant lesions of cervical cancer with cold knife reduces the risk of residual disease. Nevertheless, cryotherapy reduces the risk of minor bleeding in the 24 hours after treatment and increases the risk of recurrence of disease and infections.

14 May 2020 in ACTA MEDICA PERUANA
Verified
Journal Article
Closed access
PDF file
NBNaysha Becerra-Chauca
Naysha Becerra-Chauca
ATAlvaro Taype-Rondan
Alvaro Taype-Rondan

11 November 2025 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
EGErnesto Gozzer
Ernesto Gozzer
NBNaysha Becerra-Chauca
Naysha Becerra-Chauca
MAMohammed Abba-Aji
Mohammed Abba-Aji
VWVeronika J. Wirtz
Veronika J. Wirtz
GCGloria Cordoba
Gloria Cordoba
SKShaffi Fazaludeen Koya
Shaffi Fazaludeen Koya
Background: Antimicrobial resistance (AMR) is a critical global health challenge, linked to 4·71 million deaths in 2021 and affecting human health, animals, food, plants, and the environment. This scoping review aims to map out published interventions addressing AMR in the Latin America and Caribbean (LAC) region. Methods: We searched PubMed, Web of Science, LILACS, and grey literature for articles reporting the implementation of AMR programs, interventions, or policies aimed at tackling AMR published between January 2018 and December 2024. Results: A total of 82 studies were included, comprising 64 peer-reviewed articles and 18 from grey literature. The majority ( n = 75) focused on human health, while a smaller subset ( n = 7) addressed animal health. Geographically, most studies were conducted in Brazil ( n = 32) and Colombia ( n = 22) with only one study in the Caribbean. Antimicrobial stewardship interventions were the primary focus in 50 studies. Only 53 out of 74 studies included an evaluation of the intervention. Conclusion: Significant gaps remain in AMR research in LAC, particularly in animal and environmental health. Rigorous intervention evaluations are needed to generate high-quality evidence for policy and practice. Increased funding for intervention and implementation research across all sectors is crucial to tackling AMR regionally and globally.

30 March 2022 in Revista Colombiana de Obstetricia Y Ginecologia
Verified
Journal Article
Open access
OYOmar Yanque-Robles
Omar Yanque-Robles
NBNaysha Becerra-Chauca
Naysha Becerra-Chauca
WNWendy Nieto-Gutiérrez
Wendy Nieto-Gutiérrez
RGRaúl Alegría Guerrero
Raúl Alegría Guerrero
MUMarco Uriarte-Morales
Marco Uriarte-Morales
LCLourdes Carrera-Acosta
Lourdes Carrera-Acosta
Objetivos: proveer recomendaciones clínicas basadas en evidencia para la prevención y el manejo de la enfermedad hipertensiva del embarazo EHE en EsSalud. Materiales y métodos: se conformó un grupo elaborador de la guía (GEG) que incluyó médicos especialistas y metodólogos. El GEG formuló ocho preguntas clínicas para ser respondidas por la presente Guía de Práctica Clínica (GPC). Se realizaron búsquedas sistemáticas de revisiones sistemáticas y, cuando se consideró pertinente, estudios primarios en PubMed y Central durante 2021. Se seleccionó la evidencia para responder cada una de las preguntas clínicas planteadas. La certeza de la evidencia fue evaluada usando la metodología. En reuniones de trabajo periódicas, el GEG usó la metodología Grading of Recommendations Assessment, Development, and Evaluation (GRADE) para calificar la evidencia y formular las recomendaciones. Además se resentan los puntos de buenas prácticas clínicas (BPC) y los flujogramas de prevención, manejo y seguimiento. Finalmente, la GPC fue aprobada por Resolución 112-IETSI-ESSALUD-2021. Resultados: en la presente GPC se formularon 11 recomendaciones (6 fuertes y 5 condicionales) que respondieron las preguntas clínicas definidas en el alcance de la GPC, acompañadas de 32 BPC y 3 flujogramas que abordan temas de prevención tratamiento y seguimiento de la EHE Conclusiones: como recomendaciones centrales de la guía se dan el uso de sulfato de magnesio para el tratamiento de la preeclampsia severa y la eclampsia. La guía deberá ser actualizada en tres años.

1 May 2021 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
ABAna Brañez-Condorena
Ana Brañez-Condorena
SGSergio Goicochea-Lugo
Sergio Goicochea-Lugo
JZJessica Hanae Zafra-Tanaka
Jessica Hanae Zafra-Tanaka
NBNaysha Becerra-Chauca
Naysha Becerra-Chauca
VFVirgilio E. Failoc-Rojas
Virgilio E. Failoc-Rojas
ATAlvaro Taype-Rondan
Alvaro Taype-Rondan
BACKGROUND: The most-used equations for estimating the glomerular filtration rate (GFR) are the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) equations. However, it is unclear which of these shows better performance in Latin America. OBJECTIVE: To assess the performance of two equations for estimated GFR (eGFR) in Latin American countries. DESIGN AND SETTING: Systematic review and meta-analysis in Latin American countries. METHODS: We searched in three databases to identify studies that reported eGFR using both equations and compared them with measured GFR (mGFR) using exogenous filtration markers, among adults in Latin American countries. We performed meta-analyses on P30, bias (using mean difference [MD] and 95% confidence intervals [95% CI]), sensitivity and specificity; and evaluated the certainty of evidence using the GRADE methodology. RESULTS: We included 12 papers, and meta-analyzed six (five from Brazil and one from Mexico). Meta-analyses that compared CKD-EP I using creatinine measured with calibration traceable to isotope dilution mass spectrometry (CKD-EP I-Cr IDMS) and using MDRD-4 IDMS did not show differences in bias (MD: 055 ml/min/1.73m(2) ; 95% CI: -334 to 4.43), P30 (MD: 4%; 95% CI: -2% to 11%), sensitivity (76% and 75%) and specificity (91% and 89%), with very low certainty of evidence for bias and P30, and low certainty of evidence for sensitivity and specificity. CONCLUSION: We found that the performances of CKD-EPI-Cr IDMS and MDRD-4 IDMS did not differ significantly. However, since most of the meta-analyzed studies were from Brazil, the results cannot be extrapolated to other Latin American countries.

30 September 2021 in Revista de Gastroenterología del Perú
Verified
Journal Article
Closed access
GOGuillermo Otoya-Moreno
Guillermo Otoya-Moreno
NBNaysha Becerra-Chauca
Naysha Becerra-Chauca
HBHarold Benites-Goñi
Harold Benites-Goñi
CGCésar García-Delgado
César García-Delgado
EREduardo Ruiz-Gárate
Eduardo Ruiz-Gárate
VSVladimir Ernesto Santos Sánchez
Vladimir Ernesto Santos Sánchez
Introducción: El presente artículo resume las recomendaciones basadas en evidencia de la guía de práctica clínica (GPC) para el diagnóstico y manejo de la infección por Helicobacter pylori en enfermedades gastroduodenales. Métodos: Se conformó un grupo elaborador de la guía (GEG) que incluyó médicos especialistas y metodólogos que formuló siete preguntas clínicas a ser respondidas por la presente GPC. Se realizaron búsquedas sistemáticas de revisiones sistemáticas y -cuando se consideró pertinente- estudios primarios en PubMed y CCENTRAL durante diciembre 2019 y marzo 2020. Se seleccionó la evidencia para responder cada una de las preguntas clínicas planteadas y la certeza de la evidencia fue evaluada usando la metodología Grading of Recommendations Assessment, Development, and Evaluation (GRADE). En reuniones de trabajo periódicas, el GEG usó la metodología GRADE para revisar la evidencia y formular las recomendaciones, los puntos de buena práctica clínica y los flujogramas. Finalmente, la GPC fue aprobada con Resolución Resolución N° 104-IETSI-ESSALUD-2020. Resultados: La presente GPC abordó siete preguntas clínicas, divididas en cuatro temas. En base a dichas preguntas se formularon 12 recomendaciones (3 fuertes y 9 condicionales), 17 BPC, y dos flujogramas (uno de diagnóstico y otro de manejo). Conclusión: logía y las conclusiones basadas en evidencias de la GPC para el diagnóstico y manejo l de la infección por Helicobacter pylori en enfermedades gastroduodenales.